CTRI/2008/091/000099已完成4 期
A randomized double-blind placebo-controlled prospective evaluation of the effect of atorvastatin on pancreatic beta-cell function and insulin resistance in type-2 diabetes mellitus patients: A pilot study
Department of Pharmacology AIIMS New Delhi0 个研究点目标入组 42 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patient with type 2 diabetes mellitus not taking insulin.
- •2.Patient should not have taken statins during past 3 months.
- •3.Patients of either sex aged 18 years and above.
- •4. Patient should not be on more than two anti-diabetic drugs(Sulphonylureas & Biguanides)
- •5.LDL >99 - <161 mg/dl if patient had received Medical Nutrition Therapy (MNT) earlier at least for three months and LDL >129 - <161 mg/dl if the patient had not received MNT earlier
- •6.HbA1c >6.4 - <10
排除标准
- •1. Patient already taking statin or on insulin therapy
- •2. Deranged liver function test, renal function test
- •3. Clinically significant cardiovascular disease including history of myocardial infraction or Heart failure (NYHA class III or IV)
- •4.Pregnancy
- •5.Lactation
- •6.Drug abuse
- •7.Hypersensitivity to statins
- •8.Patients on drugs that can increase the incidence of statin induced myopathy
- •9.Patient on drugs causing hyperglycemia
研究者
相似试验
已完成
2 期
Homeopathy in knee osteoarthritisCTRI/2014/05/004589Mahesh Bhattacharyya Homoeopathic Medical College Hospital Government of West Bengal60
进行中（未招募）
1 期
Evaluation of the efficacy and safety of BactekRecurrent bronchospasmMedDRA version: 14.1Level: PTClassification code 10006482Term: BronchospasmSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2012-002450-24-ESInmunotek S.L.121
进行中（未招募）
不适用
Evaluation of the efficacy and safety of Bactek in COPDEUCTR2012-003253-28-ESInmunotek S.L.
已完成
不适用
A randomized double-blind placebo-controlled trial for improving the intestinal environment in humaJPRN-UMIN000018958ORTHOMEDICO, Inc.24
招募中
1 期
A randomized double-blind placebo-controlled study of Xianghua Compound Granule in the treatment of liver depression type insomniaiver depression type insomniaITMCTR2000003568Shanghai Traditional Chinese Medicine Hospital